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Degradation of cell nucleotides during ischemic tissue injury is well documented 
and has been characterized in some detail for several tissues (l-l 1). This process 
may contribute to cell injury by limiting the availability of nucleotide precursors 
during recovery (7-9) and as a result of deleterious effects of reactive oxygen 
metabolites generated during metabolism of hypoxanthine and xanthine by xanthine 
oxidase (12,13). Published data for the kidney have been collected during in viva 
models of renal ischemia (l-6). Zn viva studies, however, do not allow assessment 
of the individual contributions of the various different cell types within the kidney 
to the observed changes and generally sample from a rather heterogenous pattern 
of injury. The recent development of models of oxygen deprivation injury to 
isolated rabbit proximal tubules (14,15) has provided the opportunity to assess 
tubule purine nucleotide metabolism during oxygen deprivation in a particularly 
well-controlled setting which allows direct measurements in tubule cells during 
both reversible and irreversible forms of cell injury. This manuscript details the 
patterns of purine degradation produced by oxygen deprivation injury to the 
tubule preparation. 
MATERIALS AND METHODS 
Animals. New Zealand White rabbits weighing an average of 2.5 kg were used 
for these studies. 
Tubule isolation. Suspensions enriched in proximal tubules were isolated from 
renal cortex using collagenase to separate the tubules then Percoll (Pharmacia, 
Piscataway, NJ) to enrich a proximal tubule fraction as detailed in recent publications 
(14,15). 
General procedures for tubule incubation. The final tubule pellet at the end 
of the isolation procedure was resuspended to a concentration of 5-7.5 mg tubule 
protein/ml in a 95% Oz/5% CO* gassed ice-cold solution containing 105 mM 
NaCl, 2.1 mM KCl, 25 mM NaHCO,, 2.4 mM KH?PO,. 1.2 mM CaCl,, 2.5 mM 
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MgSO,, 0.6% dialyzed dextran (Pharmacia T40), 5 mM glucose, 4 mM lactate, 1 
mM alanine and 10 mM sodium butyrate. Five-milliliter aliquots of this tubule 
suspension were placed in siliconized 25ml Erlenmeyer flasks which were then 
gassed with 95% 02/5% COZ, sealed, and kept on ice until use. As they were 
needed for experiments flasks were placed in a shaking water bath at 37°C and 
were gently shaken for the desired periods of warm incubation. 
Oxygen deprivation of tubule suspensions. To oxygen-deprive the preparation, 
flasks were gassed with 95% N2/5% CO2 for 5 min. This reduces the medium 
O2 concentration to less than 10 PM which results in a high and consistent degree 
of oxygen deprivation-induced injury (14,15). The nature and degree of oxygen 
deprivation were further modulated by controlling the incubation conditions during 
oxygen deprivation to produce either hypoxic conditions at pH 7.4 or 6.6 or a 
high tubule density simulating more of the conditions present during ischemia 
in vivo (14, 15). For hypoxia studies, tubules were kept in the metabolic shaker 
for the entire duration of oxygen deprivation. In studies where a pH of 6.6 during 
hypoxia was used, hydrochloric acid was added to adjust the pH at the beginning 
of hypoxia, and, where a reoxygenation period was assessed, NaHCOj was added 
to return the pH to 7.4 at the end of hypoxia. 
To study tubules oxygen-deprived under high density pelleted conditions, the 
contents of a flask were gassed with 95% N2/5% CO2 for 5 min, then were rapidly 
transferred to a 15-ml centrifuge tube which was gassed with 95% N2/5% COZ, 
sealed, and centrifuged in a table-top centrifuge for 15-30 set, a time sufficient 
to lightly pellet all tubules at the bottom of the centrifuge tube. The tube was 
then incubated without shaking at 37°C for the desired duration of oxygen dep- 
rivation. At the end of the oxygen deprivation period these tubules were resuspended 
in the full volume of incubation medium by gently inverting the tube several 
times and either sampled or regassed with 95% 02/5% CO;, for continued incubation 
under oxygenated conditions. 
Measurement of purine levels. To measure total suspension purine levels, 0.4 
ml of tubule suspension was added to an equal volume of 12% TCA in a 1.5ml 
microcentrifuge tube which was vigorously mixed and then centrifuged. The 
supernatant was removed from the protein pellet and was neutralized and extracted 
by mixing with an equal volume of 0.5 M trioctylamine (Aldrich) in Freon-113 
(Matheson, East Rutherford, NJ). Separation of the Freon and aqueous layers 
was facilitated by a brief centrifugation. Then the aqueous layer was removed, 
filtered through 0.45-pm nitrocellulose filters, and frozen. 
To measure medium nucleotides the tubule suspension was centrifuged for 30 
set at 12,OOOg in a microcentrifuge. Then a sample of the supernatant was 
immediately added to an equal volume of 12% TCA. Subsequent steps were 
identical to those described above for measurement of total suspension nucleotide 
levels. 
In most of the studies in this manuscript adenine nucleotides were quantified 
by HPLC at an absorbance of 254 nm with a Whatman Partisil 10 SAX strong 
anion exchange column and a gradient elution system utilizing 5 mM NH4H2P04, 
pH 3.0 (Buffer A), and 0.5 M NH4H2P04, pH 4.50 (Buffer B), at a flow rate of 
1.5 ml/min. Samples were initially eluted isocratically with Buffer A for 6 min 
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to elute AMP. The percentage of B was then increased over 30 min to 50% to 
elute ADP. The percentage of B was then further increased over 5 min to 100% 
which was continued between 35 and 45 min to elute ATP. The column was 
then reequilibrated with Buffer A for 15 min prior to injection of the next sample. 
In several of the experiments nucleotides were quantified on 20-~1 aliquots of 
sample by HPLC at an absorbance of 254 nm with a Beckman (Fullerton, CA) 
C8 ion pairing reversed phase column using an isocratic mobile phase consisting 
of 19% acetonitrile, 40 mM KH2P04, 10 mM tetrabutylammonium dihydrogen 
phosphate, pH 3.5, at 24°C and a flow rate of 1 ml/min. There was good agreement 
when nucleotides were measured on the same samples by both methods. 
Intracellular nucleotide levels were estimated by subtracting the nucleotide 
levels measured in the tubule suspending medium after removal of tubules by 
high speed centrifugation from the total suspension levels. Measured nucleotides 
were factored by milligrams of total protein (16) present in the tubule suspension 
prior to separation of tubules by centrifugation. 
Nucleosides, bases, and inosine monophosphate (IMP) were determined on 5- 
~1 aliquots of sample with the same C,, column as for nucleotide measurements 
using an isocratic mobile phase consisting of 5% acetonitrile, 20 mM KH,PO,. 
20 mM tetrabutyl dihydrogen ammonium phosphate, pH 2.7, at 25°C and a flow 
rate of 1 ml/min. This procedure allows rapid, highly reproducible measurements 
but cannot be used for sample volumes in excess of 10 ~1 due to loss of definition 
of the peaks for adenosine, hypoxanthine, and xanthine. Levels of intracellular 
nucleosides are too low to resolve with this method but medium levels after 
oxygen deprivation-induced breakdown of cell nucleotides can be readily followed. 
For both the nucleotide and nucleoside assays standard curves were generated 
using purine solutions of known composition in medium used and processed as 
for tubule samples. 
Measurement of protein recovery. The proportion of total suspension protein 
recovered when tubules are rapidly separated from their medium by centrifugation 
through bromododecane is a useful index of the extent to which tubules have 
maintained their structural integrity (14,15). To assess this 0.4 ml of 12% tri- 
chloroacetic acid in a 1.5-ml microcentrifuge tube was overlaid with 0.7 ml of 
bromododecane. Tubule suspension (0.4 ml) was gently layered on the bromo- 
dodecane and was immediately centrifuged at 12,000g for 30 sec. Total suspension 
protein and protein recovered in the trichloroacetic acid layer were measured 
by the Lowry assay using bovine serum albumin as a standard (16). 
Reagents. All reagents were of the highest grade commercially available. 
Biochemial reagents were obtained from Sigma (St. Louis, MO). Allopurinol was 
used as a 13.33-mM stock solution prepared fresh daily in 15 mu NaOH. Allopurinol 
was present throughout tubule incubation at 37°C including the 15 min prior to 
oxygen deprivation, oxygen deprivation and, where studied, reoxygenation. 
Statistics. Most studies involved multigroup comparisons and repeated-measures 
designs and were, therefore, initially assessed by analysis of variance using 
models accounting for repeated measures (BMDP Statistical Software, Los Angeles, 
CA) (17). Individual group comparisons in these multigroup studies were then 
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TABLE 1 
Protein Recovery after Centrifugation through Bromododecane of Tubules Subjected 
to Oxygen Deprivation” 
Oxygen Oxygen deprivation 
deprivation + reoxygenation 
Group 1 
Hypoxia, pH 7.4 




30 min, 200 PM allopurinol 
60 min 
60 mitt, 200 PM allopurinol 
Percentage recovery’ 
40.7 2 7.0 33.6 _’ 4.1 
97.8 + 3.4* 92.6 k 5.6* 
95.5 2 4.5* 97.5 + 2.5* 
95.3 f  5.4 85.0 2 5.1 
87.3 zt 0.8 88.8 2 5.2 
73.3 2 1.7 70.2 f  2.1 
72.5 k I.8 71.3 -c 6.0 
a Protein recoveries of paired control oxygenated tubules corresponding to these experimental 
groups ranged from 90.0 to 97.8%. Group I tubules were oxygen-deprived for 30 min under the 
indicated conditons. Group II tubules were oxygen-deprived under high density conditions for the 
indicated durations. 
h Values are means 4 SE for experiments on 4-6 separate preparation. 
* P < 0.01 vs. corresponding pH 7.4 group. 
made using the Neuman-Keuls test (18). Where only two groups were being 
studied, paired or unpaired t tests were used as appropriate. 
RESULTS 
Table 1 summarizes data on the percentage of tubules sufficiently intact to be 
recovered by centrifugation through bromododecane under each of the three 
major oxygen deprivation conditions tested, hypoxia at pH 7.4, hypoxia at pH 
6.6, and high density incubation conditions. This parameter correlates well with 
other indices of cell injury (14,15) and serves as a rapid way of quantitating the 
extent of injury in this type of preparation. The majority of tubules subjected 
to oxygen deprivation under low density hypoxic conditions at pH 7.4 sustained 
severe irreversible injury and the percentage of intact tubules dropped markedly. 
In contrast, tubules handled identically except for the presence of a medium pH 
of 6.6 during the period of oxygen deprivation maintained their structural integrity. 
A similarly decreased susceptibility to irreversible injury during 30 min of oxygen 
deprivation was seen in the tubules incubated at high density as a pellet during 
oxygen deprivation. This incubation condition is accompanied by a decrease of 
pH within the tubule pellet to approximately 7.0 (14). 
Figure 1 summarizes the changes of intracellular AMP and ATP which occurred 
during each type of oxygen deprivation. As seen in vivo (l-6), ATP fell during 
oxygen deprivation and recovered with reoxygenation while AMP increased 
during oxygen deprivation and fell during recovery. Cell ATP and AMP levels 
at the end of oxygen deprivation were no higher in hypoxic tubules at pH 6.6 
than in those kept at pH 7.4; however, both nucleotides were slightly but significantly 
greater in the tubules incubated at high density than in the pH 7.4 hypoxic 
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FIG. 1. Cell AMP and ATP levels during oxygen deprivation under hypoxic conditions at pH 
7.4 or 6.6 or under high density pelleted conditions and following oxygen deprivation and 60 min 
reoxygenation under each of the same conditions. Values are means k SE for experiments on four 
to five separate tubule preparations. *P < 0.05 vs corresponding pH 7.4 hypoxia group. Control 
oxygenated preparations had ATP and AMP levels averaging 7.2 k 0.27 and 0.34 k 0.07 nmole/mg 
tubule cell protein, respectively. 
tubules. After 60 min reoxygenation cell ATP levels recovered best during the 
conditions which allowed maintenance of tubule cell integrity, hypoxia at pH 
6.6, and high density oxygen deprivation. The ATP levels measured after recovery 
from hypoxia at pH 7.4 were substantially less than those seen in control oxygenated 
tubules and in the pH 6.6 and high density groups, even when adjusted for 
differences in the number of intact cells present. 
The metabolic fate of the lost intracellular nucleotides is shown in Fig. 2 which 
summarizes changes in medium purine levels. AMP, inosine, and hypoxanthine 
were detected in substantial quantities. The largest increases during oxygen 
deprivation were of hypoxanthine. Its level contined to rise when tubules were 
reoxygenated after hypoxia at pH 7.4. Lower hypoxanthine levels were seen 
after hypoxia at pH 6.6 and high density oxygen deprivation and these did not 
decrease during reoxygenation. 
Neither adenosine nor xanthine was detected in quantities greater than the 0.3 
nmole/mg protein resolution of the assay system for those compounds under 
any of the conditions tested. IMP levels at the end of 30 min oxygen deprivation 
were 0.47 + 0.11 and 0.45 2 0.13 nmole/mg cell protein in the hypoxia, pH 
7.4, and high density groups, respectively. They decreased to less than 0.30 
nmole/mg cell protein during reoxygenation, a level similar to that seen in ox- 
ygenated control tubules. 
Figure 3 summarizes the changes of all adenine nucleotides, including ADP, 
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FIG. 2. Medium AMP, inosine, and hypoxanthine levels for the same experiments detailed in 
Fig. 1. Medium AMP levels of control oxygenated preparations were 0.21 f  0.07 nmole/mg tubule 
cell protein. Control medium inosine and hypoxanthine levels were less than 0.3 and 1.2 nmole/mg 
protein, respectively. Labels and conditions are otherwise the same as detailed for Fig. 1. 
and their nucleoside and base degradation products which occurred in each of 
the models. Presentation of the data in this format emphasizes that most recovery 
of cell ATP during reoxygenation was from the remaining cell nucleotides rather 
than from the nucleosides and bases. 
The xanthine oxidase inhibitor, allopurinol, has been reported to have beneficial 
effects on the outcome of ischemic acute renal failure in vivo in a number of 
species, including the rabbit (19-21). The minimal metabolism of hypoxanthine 
and its minimal apparent reutilization (Figs. 2 and 3) make it less likely that 
inhibition of xanthine oxidase in tubule cells can account for these actions of 
allopurinol. To directly test the effects of allopurinol, purine levels were assessed 
during 30 and 60 min of high density oxygen deprivation. Protein recovery after 
centrifugation through bromododecane for each of these experimental conditions 
KIDNEY TUBULE NUCLEOTIDE DEGRADATION 325 
o- 
pH 7.4 pH 6.6 HGH 
HYPOXIA DENSITY 
FIG. 3. Overall summary of tubule cell ATP. ADP, and AMP (TAMP) and medium AMP (MAMP), 
inosine (INO), and hypoxanthine (HX) for the experiments detailed in Fig. I. 
is summarized in Table 1 (Group II experiments). A moderate decrease was seen 
as the period of oxygen deprivation was extended from 30 to 60 min. Allopurinol 
(200 PM) did not alter the percentage protein recovery or any of several other 
parameters of cell injury. 
Concentrations of the major purine metabolites after treatment with allopurinol 
are illustrated in Fig. 4. No effects of allopurinol on the pattern of alterations 
produced by oxygen deprivation and reoxygenation were detected. Of interest, 
however, our HPLC separation procedure used to measure nucleoside levels 
clearly separated the allopurinol. Its concentration decreased during incubation 
with the appearance of a new peak having exactly the same retention time as 
pure samples of the allopurinol metabolite, alloxanthine (data not shown). 
To further test the potency of allopurinol in our experimental system, oxygenated 
tubules were incubated with 250 PM exogenous ATP (approximately 50 nmole 
ATP/mg tubule protein) with or without added xanthine oxidase. In the absence 
of xanthine oxidase, the exogenous ATP was degraded to hypoxanthine without 
substantial further metabolism. Xanthine oxidase metabolized virtually all of the 
hypoxanthine. Allopurinol did not significantly alter the metabolism of the added 
ATP in the absence of xanthine oxidase but it almost completely inhibited deg- 
radation of hypoxanthine by the xanthine oxidase (Fig. 5). 
DISCUSSION 
Purine nucleotide degradation during oxygen deprivation-induced cell injury 
has been detailed for a variety of tissues including the kidney (l-l l), but relatively 
little information has been available with regard to the contribution of renal 
tubule cells themselves as opposed to other components of the intact kidney 
including vascular endothelial cells, interstitial cells, and intravascular cells. 
The importance of such an analysis is highlighted by the extensive work on 
myocytes showing that purine degradation in those cells does not proceed sub- 
stantially beyond inosine. The hypoxanthine and uric acid formed during tissue 
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FIG. 4. Cell ATP, cell AMP, and medium hypoxanthine levels of tubule preparations subjected 
to 30 or 60 min oxygen deprivation under high density conditions (N) or oxygen deprivation plus 
reoxygenation (R) with and without 200 PM allopurinol. Values are means *SE of four to six 
experiments on separate tubule preparations. 
&hernia are largely derived from metabolism within endothelial cells (7,g). These 
are important distinctions when considering both the availability of metabolites 
for reincorporation into cell nucleotides as well as the contribution of purine 
metabolism to injurious processes such as reactive oxygen metabolite formation 
during metabolism of hypoxanthine by xanthine oxidase (12,13). Metabolites 
generated outside of the major parenchymal cell of the tissue are less available 
to participate in either of these processes. 
The bulk of the renal cortex is composed of proximal tubule cells; they are 
highly dependent on oxidative metabolism as their energy source (22) and injury 
to both outer medullary and cortical proximal tubule segments is prominent in 
experiment models of acute renal failure (23). The tubule preparation used in 
this manuscript allows for study of the metabolic consequences of oxygen dep- 
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FIG. 5. Effects allopurinol on the activity of exogenous exanthine oxidase added to the tubule 
preparation. Oxygenated tubules were treated with 250 PM exogenous ATP and various combinations 
of 0.2 U/ml xanthine oxidase (Sigma Grade III) and 200 PM allopurinol. Purines were measured 
after 75 min incubation. Values of means 2 SE for experiments on four separate tubule preparations. 
rivation directly on tubule cells without contributions from other cell types, 
permits controlled assessment of both reversible and irreversible forms of injury, 
and allows for good identification and quantification of these stages of injury. 
The results of the present studies are similar to those reported previously 
(14,15) in that severity of injury produced by oxygen deprivation was importantly 
conditioned by pH and density. Incubating tubules at pH 6.6 or at high density 
as pellets did not substantially ameliorate the ATP depletion produced by oxygen 
deprivation but prevented the loss of structural integrity which impaired recovery 
during reoxygenation. 
In severely injured tubule preparations the predominant purine present was 
hypoxanthine indicating the capacity of tubules themselves to metabolize purines 
that far. Hypoxanthine was not converted to xanthine or uric acid, suggesting 
little or no effective xanthine oxidase activity in the tubules. The absence of 
allopurinol effects on purine degradation is consistent with this. Studies of in 
viva ischemia have also failed to document substantial metabolism of hypoxanthine 
in the rabbit (4,20). In contrast, this process appears to be more prominent in 
rat (6) and dog (24) kidney. Whether xanthine oxidase is totally absent in the 
rabbit kidney is not clear from the present studies. The fact that allopurinol itself 
was apparently metabolized to alloxanthine (25) suggests that some enzyme was 
present but its activity toward its physiological substrates was low under the 
experimental conditions used. 
Not addressed in prior in vivo studies, but readily evident from the data in 
this manuscript, is the fact that hypoxanthine was not salvaged to any appreciable 
extent. Even though ATP levels did recover when hypoxic pH 7.4 tubules were 
reoxygenated, this recovery appeared to be entirely from the remaining intracellular 
nucleotides. The inability of the tubules to use hypoxanthine is similar to that 
observed when oxygenated tubules were treated with exogenous hypoxanthine 
(15). Myocytes also salvage hypoxanthine poorly, an effect which has been 
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attributed to low activity of adenylosuccinate synthetase (26). Whether this is 
also the case for tubule cells remains to be determined, but the absence of 
substantial IMP accumulation in the tubules argues against this mechanism. 
The cumulative values in Fig. 3 make it appear as if there was a moderate 
increase of the total purine pool during reoxygenation of hypoxic tubules. Rather 
than de novo synthesis this likely represents the contribution of continued guanine 
nucleotide degradation to the hypoxanthine levels measured. 
The less injured preparations, hypoxic tubules at pH 6.6 and tubules incubated 
at high density, showed much less breakdown of their adenine nucleotides to 
hypoxanthine. This suggests that the latter process is most prominent when cell 
integrity is lost. As seen in the tubules made hypoxic at pH 7.4, however, there 
was no further metabolism of the hypoxanthine and recovery of ATP levels was 
from the remaining cell nucleotides. 
Degradation of AMP may be via deamination to IMP or dephosphorylation to 
adenosine (8). There is evidence for both processes in the kidney (27-29). The 
data in this manuscript do not indicate which one predominated since neither 
adenosine nor IMP accumulated preferentially. Further studies with adenosine 
deaminase inhibitors will be required to resolve this issue. 
Inhibition of xanthine oxidase by allopurinol has been proposed as a measure 
useful for ameliorating oxygen deprivation-induced cell injury. Initial interest 
focused on the potential for allopurinol to preserve the purine pool (19) while 
more recent studies have emphasized its ability to prevent generation of reactive 
oxygen metabolites (2,13,21). The data in this paper provide little evidence to 
support either effect of allopurinol in the rabbit kidney. This is somewhat surprising 
in view of protective effects against in vivo renal ischemia which have been 
described in the rabbit (20). It is of interest, however, that the latter study failed 
to clearly document hypoxanthine metabolism to xanthine. This suggests that 
protective effects of allopurinol at the whole tissue level may involve other 
mechanisms. A similar conclusion was recently reached in studies of the effects 
of allopurinol on ischemic injury to rabbit heart (30). 
SUMMARY 
Suspensions enriched in isolated rabbit proximal tubules were subjected to 
varying degrees of oxygen deprivation-induced injury by incubating them under 
hypoxic conditions at pH 7.4 or pH 6.6 or under high density pelleted conditions 
and adenine nucleotide degradation was characterized. The major metabolite was 
hypoxanthine. Its levels increased with the extent of irreversible injury. It was 
not further degraded or salvaged. Recovery of cell ATP during reoxygenation 
was predominantly from the remaining cell nucleotides. Allopurinol did not alter 
the pattern of purine metabolism or the extent of cell injury. These observations 
provide information on the intrinsic purine metabolic capacity of renal tubule 
cells during oxygen deprivation which is relevant to understanding both the 
salvage mechanisms available in these cells as well as the contribution of purine 
metabolism to the pathogenesis of oxygen deprivation-induced tubule cell injury. 
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